Skip to main content
Premium Trial:

Request an Annual Quote

... As Canadian Gov t Awards Cepheid, Public Health Agency $675K to Develop Pathogen Detection Tech

NEW YORK, Feb. 14 (GenomeWeb News) - The Canadian government has awarded Cepheid and the Public Health Agency of Canada CA$780,000 ($675,000) to develop in-field nucleic acid assays for Ebola, Marburg, and Lassa fever viruses, Cepheid said today.


Under the agreement, Cepheid and the Public Health Agency of Canada's National Microbiology Laboratory will develop the assays over a 2-year period based on Cepheid's GeneXpert technology.


The grants will be awarded from Canada's Chemical, Biological, Radiological, and Nuclear Research and Technologies Initiative, which comprises 14 government science-based and security departments and agencies.


Cepheid will retain the rights to the developed technology along with product distribution rights, it said.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.